Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,017 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer: prospective randomized multicenter study.
Murata H, Kawano S, Tsuji S, Kamada T, Matsuzawa Y, Katsu K, Inoue K, Kobayashi K, Mitsufuji S, Bamba T, Kawasaki H, Kajiyama G, Umegaki E, Inoue M, Saito I. Murata H, et al. Among authors: kobayashi k. J Gastroenterol Hepatol. 2003 Sep;18(9):1029-33. doi: 10.1046/j.1440-1746.2003.03093.x. J Gastroenterol Hepatol. 2003. PMID: 12911658 Clinical Trial.
Combination of enprostil and cimetidine is more effective than cimetidine alone in treating gastric ulcer: prospective multicenter randomized controlled trial.
Murata H, Kawano S, Tsuji S, Tsujii M, Hori M, Kamada T, Matsuzawa Y, Katsu K, Inoue K, Kobayashi K, Mitsufuji S, Bamba T, Kawasaki H, Kajiyama G, Umegaki E, Inoue M, Saito I. Murata H, et al. Among authors: kobayashi k. Hepatogastroenterology. 2005 Nov-Dec;52(66):1925-9. Hepatogastroenterology. 2005. PMID: 16334808 Clinical Trial.
Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01.
Siena S, Raghav K, Masuishi T, Yamaguchi K, Nishina T, Elez E, Rodriguez J, Chau I, Di Bartolomeo M, Kawakami H, Suto F, Koga M, Inaki K, Kuwahara Y, Takehara I, Barrios D, Kobayashi K, Grothey A, Yoshino T. Siena S, et al. Among authors: kobayashi k. Nat Commun. 2025 Jan 15;16(1):704. doi: 10.1038/s41467-025-56170-9. Nat Commun. 2025. PMID: 39814812 No abstract available.
Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia.
Neyama H, Wu Y, Nakaya Y, Kato S, Shimizu T, Tahara T, Shigeta M, Inoue M, Miyamichi K, Matsushita N, Mashimo T, Miyasaka Y, Dai Y, Noguchi K, Watanabe Y, Kobayashi M, Kobayashi K, Cui Y. Neyama H, et al. Among authors: kobayashi k. Sci Adv. 2025 Jan 17;11(3):eadp8494. doi: 10.1126/sciadv.adp8494. Epub 2025 Jan 15. Sci Adv. 2025. PMID: 39813331
Advantage of spirometry over oscillometry to detect dupilumab's effect on small airway dysfunction.
Shirai T, Hirai K, Akamatsu T, Mizumura K, Sasano H, Harada N, Tanaka A, Sagara H, Masaki K, Fukunaga K, Kobayashi K, Nagase H, Miyahara N, Kanehiro A, Kitamura N, Sugihara N, Terada-Hirashima J, Hojo M, Chibana K, Tagaya E, Gon Y. Shirai T, et al. Among authors: kobayashi k. Allergol Int. 2025 Jan 13:S1323-8930(24)00161-8. doi: 10.1016/j.alit.2024.12.004. Online ahead of print. Allergol Int. 2025. PMID: 39809630 Free article. No abstract available.
Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study.
Shindo T, Hashimoto K, Kenuka T, Miyamoto S, Hiyama Y, Fukuta F, Kunishima Y, Okada M, Matsukawa M, Kato R, Senda M, Wanifuchi A, Sato S, Kobayashi K, Tanaka T, Masumori N; Sapporo Medical University Urologic Oncology Consortium. Shindo T, et al. Among authors: kobayashi k. J Geriatr Oncol. 2025 Jan 9;16(2):102183. doi: 10.1016/j.jgo.2024.102183. Online ahead of print. J Geriatr Oncol. 2025. PMID: 39793527
12,017 results
You have reached the last available page of results. Please see the User Guide for more information.